Health-related Grants

Ultragenyx offers Health-related Grants to support initiatives that benefit the rare disease community, healthcare education, and local organizations. Applications must be submitted at least 30 days prior to the decision date or 60 days before the program start. Eligible areas include patient advocacy, education, community events, scientific meetings, disease awareness, and research programs. Interested parties are encouraged to apply early for thorough review and notification.

NOTE: We require all funding applications be submitted through our Grants Portal
Requests for grant funding should be submitted 30 days prior to the date you require a decision or a minimum of 60 days prior to your program start date, though longer periods are encouraged. All applications are formally and thoughtfully reviewed by a dedicated committee(s) of representatives. Once submitted, you will be notified by email with our decision.
Grants and contributions
Ultragenyx is committed to supporting initiatives that provide impactful resources for the rare disease community, healthcare education, STEAM education, and local community organizations.
Health-Related Grant Funding
Sponsorships and Grants for non-profit patient organizations and for-profit health institutions in support of:
Patient Advocacy Focused InitiativesPatient EducationPatient, Family, and Caregiver Meetings and EventsPatient Community EventsScientific Meetings (non-accredited)Disease Awareness CampaignsResearch ProgramsMedical Publications (Europe and Latin America only)FellowshipsSponsorships

Eligibility

We are currently considering Health-Related Grant Funding in the following areas:Bone Endocrine: X-Linked HypophosphatemiaTumor Induced OsteomalaciaOsteogenesis ImperfectaMetabolics: Mucopolysaccharidosis Type VII Long Chain Fatty-Acid Oxidation DisordersGlycogen Storage Disease (GSD) Type Ia and Type IIIOrnithine Transcarbamylase Deficiency Wilson Disease Creatine Transporter Deficiency Homozygous Familial Hypercholesterolemia (HoFH)Central Nervous System and Neurology: Angelman Syndrome Duchenne Muscular Dystrophy CDKL5